EDITORIAL SECTION

Articles

Post-Pandemic Trends: Reshaping the Future of European Pharma

The widespread influence of the COVID pandemic has deeply affected industries worldwide and the European pharmaceutical sector is no stranger to this impact This article delves into the lasting repercussions of the pandemic

The Role of European Pharma in Global Healthcare Advancements

Europe is one of the largest players in the international market for health care due to research development and innovation and competitive pharmaceutical industries Some of these European pharma medical research organizations and health care systems have continually provided valuable solutions to the welfare of people globally It is an increasingly important role for them to play given that they...

Revolutionizing Health: The Future of Gene Editing and Genetic Engineering

In the realm of healthcare few advancements hold as much promise and controversy as gene editing and genetic engineering These technologies once confined to science fiction are now tangible tools

mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles

During recent decades biopharmaceuticals such as monoclonal antibodies peptides or nucleic acids have gained impressive attention as revolutionary therapeutics and vaccine strategies attempting to fulfil the high expectations of resolving serious health conditions Regarding nucleic acids DNA and mRNAbased technologies have been established as extremely promising approaches in therapy and preventio...

Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics

People respond very differently to medications depending on their weight age inborn capability to metabolize drugs the individual characteristics of the disease or the presence of comorbidities The wellknown assumption that one size fits all has clearly revealed all its limitations and become questionable Notably among humans pediatric patients represent

Innovative Pricing Models in the EU: Making Medicines Affordable for All

Pricing policies are important determinants in delivering sufficiently cheap medicines in all the member nations of the EU High costs of meeting the required medical care together with arising independent differentiated technological improvements have rendered exhausted pricing structures as uncompetitive tools for fairness New mechanisms of pricing have been introduced

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG

PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys